Currently, there are 198 pharmaceutical factories in the industry that meet GMP standards of the World Health Organization, 11 factories have invested and met the standards of advanced countries such as those of Europe, the US and Japan. Edition, PIC / S. The total market value of the pharmaceutical industry in 2019 is estimated at US $ 6.6 million, the proportion of which is mainly from imported pharmaceuticals.

Although per capita consumption of Vietnam is growing with CAGR (2012-2019) reaching 12.7%. The growth of the market for prescription drugs will exceed that of over-the-counter medicines. The market value of Patent drugs in Vietnam is tending to increase. The World Health Organization WHO has ranked Vietnam on the list of countries with the highest percentage of people using antibiotics and antibiotic resistance in the world. Despite the decline in consumption value in 2017, by 2018, it is estimated that the consumption value of this product group continues to increase sharply.

In general, pharmaceutical production in Q1 / 2020 prospered over the same period last year. In particular, the group with the strongest increase over the same period in 2019 is other unallocated pharmaceutical products reaching 4.7 million kg, up 81.17% over the same period in 2019.

 

 

 

Abbreviations
Report summary
1. Business environment
1.1. Macroeconomic situation
1.2. Legal framework
1.3. Trade Agreements
2. Pharmaceutical Industry Overview
2.1. Global Pharmaceutical Industry
2.1.1. Production – Consumption
2.1.2. Export – Import
2.1.3. Production and Consumption Situation in major countries
2.1.4. Large Enterprises in the world
2.2. Vietnam Pharmaceutical Industry Overview
2.2.1. History of Vietnam Pharmaceutical Industry
2.2.2. Industry Position
2.2.3. Industry Scale and Feature
2.2.4. Value Chain of Vietnam Pharmaceutical Industry
2.2.5. Raw materials
2.2.6. Production technology
2.2.7. R&D
2.2.8. Production
2.2.9. Consumption
2.2.10. Export – Import
2.2.11. Price movements
2.2.12. Distribution system
2.3. Risks and challenges
2.4. Industry planning
2.5. Driving forces and forecast
3. Enterprise analysis
3.1. Profitability Ratios
3.2. Cost structure
3.3. Asset Management Ratios
3.4. Capital Structure
3.5. Solvency
3.6. Return on Investment
4. Appendix of financial statements
 
 

 

DHG Pharmaceutical Joint Stock Company

TRAPHACO Joint Stock Company

Domesco Medical Import Export JSC

Imexpharm Pharmaceutical JSC

OPC Pharmaceutical JSC

S.P.M JSC

Vimedimex Medi – Pharma JSC

Ha Tay Pharmaceutical JSC

Ben Tre Pharmaceutical JSC

Lam Dong Pharmaceutical JSC

 

 

 

List of charts
Figure 1: Share of health sector and social assistance activities in total GDP, 2012-Q1 / 2020
Figure 2: Population and population growth, 2010-2019
Figure 3: Consumer price index of medicines and health services, 2012 – 2012-Q1 / 2020
Figure 4: VND / USD exchange rate, 1/2013-Q1 / 2020
Figure 5: VND / CNY exchange rate, 1/2016 – Q1 / 2020
Figure 6: Number of new drugs licensed by the FDA, 2010 – 2019
Figure 7: Global R&D investment cost, 2010 – 2024f
Figure 8: Top 10 enterprises with the largest R&D costs, 2018
Figure 9: Top 10 enterprises with the largest R&D costs, 2024
Figure 10: Global pharmaceutical industry revenue, 2010 – 2019e
Figure 11: Degree of risk from patent protection, 2012-2019e
Figure 12: Global sales of prescription and genric drugs, 2010 – 2019e
Figure 14: Share of pharmaceutical sales by technology, 2010 – 2019e
Figure 15: Consumption market share by group, 2018
Figure 16: World drug spending by field of treatment *, 2018
Figure 17: World pharmaceutical exports, 2010 – 2019
Figure 18: Net revenue of manufacturers per capita, 2014-2019e
Figure 19: Revenue growth of Chinese pharmaceutical products, Q1 / 2019-Q1 / 2020
Figure 20: World’s top 10 pharmaceutical enterprises by revenue and R&D costs, 2019
Figure 21: Import of raw materials, 2014 – Q1 / 2019e
Figure 22: Import of pharmaceutical raw materials, Q1 / 2019 – Q1 / 2020
Figure 23: Number of enterprises and employees in medicine, chemical and pharmaceutical production, 2010 – 2018
Figure 24: Average capital, fixed assets and long-term investment by enterprise, 2010-2018
Figure 25: Revenue and profit before tax, 2010 – 2018
Figure 26: Domestic production value of pharmaceuticals, 2013 – 2019e
Figure 27: Market value of pharmaceutical industry, 2013 – 2019e
Figure 28: Share of value of domestically produced drugs in Vietnam, 2010 – 2019e
Figure 29: Domestic consumption of drugs, 2013 – Q1 / 2020
Figure 30: Drug spending in Vietnam, 2009 – 2019e
Figure 31: Percentage of drug spending / total health expenditure in some countries, 2018e
Figure 32: Structure of drug consumption by channel, 2013 – 2019e
Figure 33: Actual situation of Pantented and Generic drugs, 2013 – 2019e
Figure 34: Market value of prescription drugs (ETC), 2011 – 2019e
Figure 35: Market of over-the-counter medicines (OTC), 2011 – 2019e
Figure 36: OTC market share by selling channel, 2019e
Figure 37: Patent drug (Patent), 2011 – 2019e
Figure 38: Generic drug market, 2013 – 2019e
Figure 39: Import of pharmaceutical products, 2012 – Q1 / 2020
Figure 40: Import of pharmaceutical products from some countries, Q1 / 2019-Q1 / 2020
 
Figure 41: Import of pharmaceutical products from India, 2012 – Q1 / 2020
Figure 42: Top major exporting countries, Q1 / 2020
Figure 43: Export of pharmaceutical products, 2012 – Q1 / 2020
Figure 44: Consumer price index of medicines and health services, 2012-Q1 / 2020
Figure 45: Top of distribution enterprises by revenue, 2018e
Figure 46: Sales of typical distribution chains, 2017 – 2018
Figure 47: Unqualified sample rate, 2010 – 2018
Figure 48: M&A of pharmaceutical industry, 2010 – Q1 / 2020
Figure 49: Revenue of prescription drugs, 2017-2024f
Figure 50: Prescription drug revenue of the top 10 largest companies, 2024f
Figure 51: Drug production by technology, 2017 – 2024f
Figure 52: Growth of total drug consumption value in Vietnam, 2013 – 2023f
Figure 53: Drug expenditure per capita, 2017 – 2023f
 
List of tables
Table 1: Drug exporting countries, 2017-2019
Table 2: Countries importing drugs, 2017-2019
Table 3: General information about the US health sector, 2018e
Table 4: General information about Japanese health sector, 2018e
Table 5: General information about the German health sector, 2018e
Table 6: Origin of machinery and equipment of some large pharmaceutical manufacturers
Table 7: Some of the main equipment in the pharmaceutical production line
Table 8: Average R&D costs for new drug production
Table 9: Statistics of drug production by categories, 2014 – Q1 / 2020
Table 10: M&A of pharmaceutical manufacturing group, 2016 – 2019
Table 11: Vietnam’s top import partners, Q1 / 2020
Table 12: Top pharmaceutical importing enterprises, Q1 / 2020
Table 13: Top exporting enterprises, Q1 / 2020
Table 14: Statistics of differences in selling prices of some drugs at pharmacies, 2019
Table 15: Number of health facilities, 2012 – 2017
Table 16: Typical pharmacy chains, 2019
Table 17: M&A of pharmaceutical distribution group, 2017 – 2019
Table 18: Average R&D costs for new drug production (USD million)
Table 19: World’s top 15 M&A, Q1 / 2020
Table 20: Top enterprises using Biotechnology, 2024
Table 21: 10 typical businesses of the pharmaceutical industry in 2019